N. Gilzeane

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

H. H. Jensen, P. Wilding, S. Pocock, 2017, The Lancet.

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, Johshua N. Fletcher, 2019, The Lancet. Neurology.

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, M. Dennis, 2019, Lancet.

Strategic race blindness: not so black and white?

Vincent Egan, N. Gilzeane, M. Viskaduraki, 2013 .

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

C. Sudlow, P. Sandercock, D. Werring, 2018, Trials.